Q2 2022 Holdings
Filed 2022-08-15 | 89 holdings | $158.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Centene Corp del(CNC) | COM | 15135B101 | $68.3M | 807,438 | 43.1% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $51.5M | 2,321,800 | 32.5% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $21.0M | 1,125,112 | 13.2% |
| Conocophillips(COP) | COM | 20825C104 | $10.0M | 110,798 | 6.3% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $5.4M | 600,000 | 3.4% |
| Royalty Pharma PLC(RPRX) | SHS CLASS A | G7709Q104 | $129.4K | 3,078,506 | 0.1% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $123.8K | 240,997 | 0.1% |
| Union PAC Corp(UNP) | COM | 907818108 | $113.5K | 532,015 | 0.1% |
| LAS Vegas Sands Corp(LVS) | COM | 517834107 | $97.5K | 2,903,711 | 0.1% |
| Humana Inc(HUM) | COM | 444859102 | $92.5K | 197,668 | 0.1% |
| Otis Worldwide Corp(OTIS) | COM | 68902V107 | $91.7K | 1,297,480 | 0.1% |
| Iqvia Hldgs Inc(IQV) | COM | 46266C105 | $85.1K | 392,045 | 0.1% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $76.4K | 1,338,700 | 0.0% |
| Lauder Estee COS Inc(EL) | CL A | 518439104 | $74.6K | 292,979 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $73.6K | 4,017,000 | 0.0% |
| Tapestry Inc(TPR) | COM | 876030107 | $68.6K | 2,247,709 | 0.0% |
| Mastercard Incorporated(MA) | CL A | 57636Q104 | $66.0K | 209,111 | 0.0% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $65.9K | 121,375 | 0.0% |
| Microsoft Corp(MSFT) | COM | 594918104 | $64.2K | 250,157 | 0.0% |
| Visa Inc(V) | COM CL A | 92826C839 | $64.0K | 324,818 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $63.9K | 951,986 | 0.0% |
| Danaher Corporation(DHR) | COM | 235851102 | $55.3K | 218,222 | 0.0% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $44.7K | 2,470,559 | 0.0% |
| Amerisourcebergen Corp(COR) | COM | 03073E105 | $44.5K | 314,691 | 0.0% |
| Canadian PAC RY LTD | COM | 13645T100 | $44.3K | 634,056 | 0.0% |
| Block Inc(XYZ) | CL A | 852234103 | $41.8K | 679,676 | 0.0% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $41.0K | 2,078,680 | 0.0% |
| Viatris Inc(VTRS) | COM | 92556V106 | $40.6K | 3,881,900 | 0.0% |
| Fidelity Natl Information SV(FIS) | COM | 31620M106 | $40.6K | 443,240 | 0.0% |
| Hilton Worldwide Hldgs Inc(HLT) | COM | 43300A203 | $40.2K | 360,491 | 0.0% |
| Marriott Intl Inc New(MAR) | CL A | 571903202 | $39.8K | 292,687 | 0.0% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $38.8K | 486,661 | 0.0% |
| Kezar Life Sciences Inc | COM | 49372L100 | $36.5K | 4,412,300 | 0.0% |
| Mckesson Corp(MCK) | COM | 58155Q103 | $34.2K | 104,802 | 0.0% |
| Disney Walt Co(DIS) | COM | 254687106 | $33.1K | 350,926 | 0.0% |
| Global Pmts Inc(GPN) | COM | 37940X102 | $31.8K | 287,222 | 0.0% |
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $31.2K | 1,784,200 | 0.0% |
| RH(RH) | COM | 74967X103 | $28.3K | 133,325 | 0.0% |
| Marqeta Inc(MQ) | CLASS A COM | 57142B104 | $28.1K | 3,463,704 | 0.0% |
| Exxon Mobil Corp(XOM) | COM | 30231G102 | $24.9K | 290,732 | 0.0% |
| Sutro Biopharma Inc | COM | 869367102 | $24.2K | 4,645,000 | 0.0% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $23.4K | 2,968,207 | 0.0% |
| GFL Environmental Inc(GFL) | SUB VTG SHS | 36168Q104 | $23.3K | 903,132 | 0.0% |
| Monster Beverage Corp New(MNST) | COM | 61174X109 | $23.2K | 249,802 | 0.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $20.8K | 348,519 | 0.0% |
| Point Biopharma Global Inc | COM | 730541109 | $20.5K | 3,014,408 | 0.0% |
| Match Group Inc New(MTCH) | COM | 57667L107 | $20.1K | 287,786 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $19.0K | 1,928,200 | 0.0% |
| Pharvaris N V(PHVS) | COM | N69605108 | $18.3K | 827,540 | 0.0% |
| Marinus Pharmaceuticals Inc(MRNS*) | COM NEW | 56854Q200 | $17.0K | 3,510,831 | 0.0% |